Resumen Clínico de Paciente de Chile (IPS-CL)
0.2.0 - ci-build Chile flag

This page is part of the Resumen Clinico de Paciente de Chile (v0.2.0: STU1 Draft) based on FHIR (HL7® FHIR® Standard) R4. . For a full list of available versions, see the Directory of published versions

Resource Profile: RegMedicamentosClIps - Mappings

Draft as of 2024-11-14

Mappings for the RegMedicamentos-cl-ips resource profile.

Mappings for Workflow Pattern (http://hl7.org/fhir/workflow)

RegMedicamentosClIps
MedicationStatementEvent
   identifierEvent.identifier
   basedOnEvent.basedOn
   partOfEvent.partOf
   statusEvent.status
   statusReasonEvent.statusReason
   medication[x]Event.code
   subjectEvent.subject
   contextEvent.context
   effective[x]Event.occurrence[x]
   reasonCodeEvent.reasonCode
   reasonReferenceEvent.reasonReference
   noteEvent.note

Mappings for RIM Mapping (http://hl7.org/v3)

RegMedicamentosClIps
MedicationStatementEntity. Role, or Act, SubstanceAdministration
   textAct.text?
   containedN/A
   extensionN/A
   modifierExtensionN/A
   identifier.id
   basedOn.outboundRelationship[typeCode=FLFS].target[classCode=SBADM or PROC or PCPR or OBS, moodCode=RQO orPLAN or PRP]
   partOf.outboundRelationship[typeCode=COMP]/target[classCode=SPLY or SBADM or PROC or OBS,moodCode=EVN]
   status.statusCode
   statusReason.inboundRelationship[typeCode=SUBJ].source[classCode=CACT, moodCode=EVN].reasonCOde
   category.inboundRelationship[typeCode=COMP].source[classCode=OBS, moodCode=EVN, code="type of medication usage"].value
   medication[x].participation[typeCode=CSM].role[classCode=ADMM or MANU]
   subject.participation[typeCode=SBJ].role[classCode=PAT]
      idn/a
      extensionn/a
      referenceN/A
      typeN/A
      identifier.identifier
      displayN/A
   context.inboundRelationship[typeCode=COMP].source[classCode=ENC, moodCode=EVN, code="type of encounter or episode"]
   effective[x].effectiveTime
      idn/a
      extensionn/a
      extension (data-absent-reason)ANY.nullFlavor
   dateAsserted.participation[typeCode=AUT].time
   informationSource.participation[typeCode=INF].role[classCode=PAT, or codes for Practioner or Related Person (if PAT is the informer, then syntax for self-reported =true)
   derivedFrom.outboundRelationship[typeCode=SPRT]/target[classCode=ACT,moodCode=EVN]
   reasonCode.reasonCode
   reasonReference.outboundRelationship[typeCode=RSON]/target[classCode=OBS,moodCode=EVN, code="reason for use"].value
   note.inboundRelationship[typeCode=SUBJ]/source[classCode=OBS,moodCode=EVN,code="annotation"].value
   dosagerefer dosageInstruction mapping
      idn/a
      extensionn/a
      modifierExtensionN/A
      sequence.text
      text.text
      additionalInstruction.text
      patientInstruction.text
      timing.effectiveTime
      asNeeded[x].outboundRelationship[typeCode=PRCN].target[classCode=OBS, moodCode=EVN, code="as needed"].value=boolean or codable concept
      site.approachSiteCode
      routen/a, CD
      method.doseQuantity
      doseAndRate
         idn/a
         extensionn/a
         dose[x].doseQuantity
         rate[x].rateQuantity
      maxDosePerPeriod.maxDoseQuantity
      maxDosePerAdministrationnot supported
      maxDosePerLifetimenot supported

Mappings for FiveWs Pattern Mapping (http://hl7.org/fhir/fivews)

RegMedicamentosClIps
MedicationStatement
   identifierFiveWs.identifier
   statusFiveWs.status
   categoryFiveWs.class
   medication[x]FiveWs.what[x]
   subjectFiveWs.subject[x], FiveWs.subject
   effective[x]FiveWs.done[x]
   dateAssertedFiveWs.recorded
   informationSourceFiveWs.source
   reasonCodeFiveWs.why[x]
   reasonReferenceFiveWs.why[x]

Mappings for HL7 v2 Mapping (http://hl7.org/v2)

RegMedicamentosClIps
MedicationStatement
   subjectPID-3-Patient ID List
   dosage
      sequenceTQ1-1
      textRXO-6; RXE-21
      additionalInstructionRXO-7
      patientInstructionRXO-7
      asNeeded[x]TQ1-9
      siteRXR-2
      routeCE/CNE/CWE
      methodRXR-4
      doseAndRateTQ1-2
         typeRXO-21; RXE-23
         dose[x]RXO-2, RXE-3
         rate[x]RXE22, RXE23, RXE-24
      maxDosePerPeriodRXO-23, RXE-19